Pro
US-based private equity giant KKR & Co. Inc sold a part of its stake in an Indian drugmaker on Thursday, scoring multibagger returns on the investment it made more than four-and-a-half years ago. The New York-listed PE firm, which has struck four transactions in India’s healthcare sector over the last ten ......